Championing Change: Optimizing Plasmid Production Strategies

Identifying the right plasmid supplier to help manufacture your biologic is a critical decision that can help ensure reliable timelines and reduce risk. There are several critical factors to consider, including a contract development and manufacturing organization’s (CDMO’s) product quality and analytical testing offerings, their ability to maintain timelines, and whether they offer a pressure tested quality system for good manufacturing practice (GMP) production. In a recent webinar hosted by Ajinomoto Bio-Pharma Services, Erika Morris, Director of Business Intelligence and Business Development, offered her insight into how to avoid common plasmid production pitfalls and identify an experienced, capable plasmid supplier. In the post-webinar Q&A session, Erika tackled questions on best practices for dealing with inconsistent yields and implementing risk mitigation throughout plasmid production. Download the full Q&A article to read her insights.